Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance

被引:61
作者
Mauvais-Jarvis, F
Kulkarni, RN
Kahn, CR
机构
[1] Hop St Louis, Dept Endocrinol & Diabet, F-75010 Paris, France
[2] Univ Paris 07, Sch Med, Inst Cochin Genet Mol, CNRS,UPR 1524, Paris, France
[3] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1046/j.1365-2265.2002.01563.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE The development of type 2 diabetes is linked to insulin resistance coupled with a failure of pancreatic beta-cells to compensate by adequate insulin secretion. DESIGN Here, we review studies obtained from genetically engineered mice that provide novel insights into the pathophysiology of insulin resistance. RESULTS Knockout models with monogenic impairment in insulin action have highlighted the potential role for insulin signalling molecules in insulin resistance at a tissue-specific level. Polygenic models have strengthened the idea that minor defects in insulin secretion and insulin action, when combined, can lead to diabetes, emphasizing the importance of interactions of different genetic loci in the production of diabetes. Knockout models with tissue-specific alterations in glucose or lipid metabolism have dissected the individual contributions of insulin-responsive organs to glucose homeostasis. They have demonstrated the central role of fat as an endocrine tissue in the maintenance of insulin sensitivity and the development of insulin resistance. Finally, these models have shown the potential role of impaired insulin action in pancreatic beta-cells and brain in the development of insulin deficiency and obesity.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 65 条
[31]   Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines [J].
Kulkarni, RN ;
Winnay, JN ;
Daniels, M ;
Brüning, JC ;
Flier, SN ;
Hanahan, D ;
Kahn, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (12) :R69-R75
[32]  
KULKARNI RN, 2001, 83 ANN END SOC M 20, P84
[33]   Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue [J].
Lauro, D ;
Kido, Y ;
Castle, AL ;
Zarnowski, MJ ;
Hayashi, H ;
Ebina, Y ;
Hayashi, H ;
Accili, D .
NATURE GENETICS, 1998, 20 (03) :294-298
[34]   Insulin receptor substrate 3 is not essential for growth or glucose homeostasis [J].
Liu, SCH ;
Wang, Q ;
Lienhard, GE ;
Keller, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :18093-18099
[35]  
MARBAN SL, 1992, DIABETES, V41, pA145
[36]  
MARBAN SL, 1990, DIABETES, V39, pA59
[37]   Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal Yellow agouti mutation -: Usefulness of leptin for the treatment of obesity-associated diabetes [J].
Masuzaki, H ;
Ogawa, Y ;
Aizawa-Abe, M ;
Hosoda, K ;
Suga, J ;
Ebihara, K ;
Satoh, N ;
Iwai, H ;
Inoue, G ;
Nishimura, H ;
Yoshimasa, Y ;
Nakao, K .
DIABETES, 1999, 48 (08) :1615-1622
[38]   Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes [J].
Mauvais-Jarvis, F ;
Ueki, K ;
Fruman, DA ;
Hirshman, MF ;
Sakamoto, K ;
Goodyear, LJ ;
Iannacone, M ;
Accili, D ;
Cantley, LC ;
Kahn, CR .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (01) :141-149
[39]   A model to explore the interaction between muscle insulin resistance and β-cell dysfunction in the development of type 2 diabetes [J].
Mauvais-Jarvis, F ;
Virkamaki, A ;
Michael, MD ;
Winnay, JN ;
Zisman, A ;
Kulkarni, RN ;
Kahn, CR .
DIABETES, 2000, 49 (12) :2126-2134
[40]   Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction [J].
Michael, MD ;
Kulkarni, RN ;
Postic, C ;
Previs, SF ;
Shulman, GI ;
Magnuson, MA ;
Kahn, CR .
MOLECULAR CELL, 2000, 6 (01) :87-97